Skip to Content

Oncolytics Biotech Inc

Rating as of

Company Profile

Business Description

Oncolytics Biotech Inc is a development stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Opdivo, and Tecentriq.

1167 Kensington Crescent North West, Suite 210
Calgary, AB, T2N 1X7, Canada
T +1 403 670-7377
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type
Employees 23